PROGRAM SUMMARY:
Design of manufacturing facilities for the production of Pharmaceuticals has been a focus of more and more companies in the region. Time to market, quality and scalability all play a part in driving innovation with continuous manufacturing.
Continuous Manufacturing platforms are being developed by many firms to address capacity and repeatability concerns. Hear from experts from leading firms and take part in an open forum on Continuous Manufacturing.
Join us for a timely discussion of this compelling topic, learn about the application of this technology and join your Boston Chapter community in welcoming these leaders driving technology.
WHO SHOULD ATTEND:
This program will appeal to people across organizations developing or delivering manufacturing programs, supporting vendors and consultants.
Individuals or organizations considering manufacture of pharmaceuticals with continuous processing should attend. Be part of the discussion and learn from thought leaders in this space. Learn how to put to work the technologies that can drive efficiency and quality in your manufacturing platform.
LOCATION:
Takeda, 35 Landsdown St, Cambridge, MA 02139
PROGRAM SCHEDULE:
5:30 - 6:30 PM – Registration and Networking Reception
6:30 - 6:40 PM – Introductions
6:40 - 8:30 PM - Panel + Q&A Discussion
SPEAKERS:
Salvatore Mascia, CEO, CONTINUUS Pharmaceuticals
Salvatore Mascia is the Founder & CEO of CONTINUUS Pharmaceuticals. He was the former Strategic Project Manager at the Novartis-MIT Center for Continuous Manufacturing, where he led the integration of the first end-to-end continuous manufacturing process for pharmaceuticals. At the end of the project, he was presented with the “Leadership Award” that recognized his leadership role at the Center. Salvatore has gained experience in strategic management and fund raising in addition to leadership skills via various roles of responsibility within the entrepreneurial ecosystem. Among those, he co-founded “Professionisti Italiani a Boston” in 2009, and served as President of the “Cambridge University Technology and Enterprise Club” in 2006/07. He also ran a pharmacy business for 2 years. Salvatore completed a post-doc at MIT in Chemical Engineering and holds a PhD in Chemical Engineering from the University of Cambridge, UK and a BS and MS in Pharmacy (summa cum laude) from University of Perugia, Italy.
Lynne Frick, 4th Dimension Bioprocess, Inc. CEO & BioInnovation Group, Inc., Co–Executive Director
Lynne is CEO of 4th Dimension Bioprocess, a new Boston-based Continuous Bioprocessing CDMO applying production line thinking, an innovative technology sandbox and extensive automation to meet the challenges of modernizing Biomanufacturing.
She is also the founder and co-executive director of the BioInnovation Group, a for public benefit corporation consisting of senior industry professionals who provide guidance to technology companies on the adoption criteria and customer needs in Biopharmaceutical development and manufacturing.
Kevin Brower, Head of Purification Development, Sanofi
Kevin Brower works at Sanofi as the Head of Purification Development in Framingham. He has been with Sanofi and Genzyme for almost 10 years. Kevin’s team is responsible for early and late stage purification process development for protein biologics, including mAbs, enzymes, and blood factors. Additionally, his team is responsible for technology development in high throughput process development and integrated and continuous biomanufacturing, including the development and implementation of Sanofi’s first ICB platform for commercial manufacturing, in collaboration with colleagues across the company. Kevin received his Bachelors in Chemical Engineering from Yale University and his Masters and PhD in Chemical Engineering from MIT.
Michael O’Connor, Senior Engineer, Pfizer
Michael O'Connor is a Senior Engineer at Pfizer with 10 years of experience across development, scale up, and commercial drug substance manufacturing operations for biologics and vaccines. He is currently focused on the development and implementation of an integrated modular platform for continuous drug substance manufacturing as part of a cross-functional multi-company collaboration. He received Bachelor and Master of Science degrees in Chemical Engineering from the University of New Hampshire.
MODERATOR:
Samir Gondalia, Director CQV, DPS Group
Samir Gondalia is a pharmaceutical industry veteran with 20+ years’ engineering, manufacturing, CQV, and quality experience in GMP pharmaceutical facilities. He is currently working as a Director, CQV Project Management at DPS Group Global. He worked for Pfizer, Inc for 19+ years where he led and mentored cross-functional teams in Drug Discovery, R & D, Pilot, clinical and commercial manufacturing, greenfield site development, and regulatory in the USA, and China. He worked with a team to provide the Proof of Concept for the biologics continuous manufacturing skid at Pfizer. On behalf of ISPE, he hosts the podcast, The Future of Pharma, an interview style podcast with the thought leaders of the industry.
REGISTRATION FEES:
Early Bird (Ends 3/12/2020)
Member: $50
Non-Member: $95
ISPE Young Professionals Member: $20
ISPE Student Members: FREE
After 3/12/2020
Member: $60
Non-Member: $115
ISPE YCls Member: 30
ISPE Student Members: FREE
MEETING MANAGERS:
Kathleen Mihlbachler, YMC Process Technologies
Jim Grunwald, DPS Group
Thank you to our program sponsors!
DPS Group
ICQ